Table 1.
Number and percentage of children reaching adequate RVNA concentrations (≥0.5 IU/mL) after administration of simulated post-exposure booster doses, 1, 3, or 5 years after two or three primary vaccination doses, as determined by RFFIT.
| Group | 1-year | 3-year | 5-year | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| pre | D7 | D14 | D365 | pre | D7 | D14 | D365 | Pre | D7 | D14 | D365 | |
| 2d | (6/84) | (81/84) | (81/81) | (51/77) | (4/48) | (35/48) | (47/47) | (24/41) | (10/82) | (75/82) | (79/79) | (29/57) |
| % | 7% | 96% | 100% | 66% | 8% | 73% | 100% | 59% | 12% | 91% | 100% | 51% |
| 3d | (22/63) | (61/61) | (58/58) | (55/59) | (24/60) | (58/60) | (57/57) | (45/52) | (41/89) | (88/89) | (85/85) | (59/62) |
| % | 35% | 100% | 100% | 93% | 40% | 97% | 100% | 87% | 46% | 99% | 100% | 95% |
2d: two-dose primary vaccination; 3d: three-dose primary vaccination; pre: before booster.